Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) traded up 1.2% during trading on Wednesday . The company traded as high as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). 495,137 shares traded hands during trading, an increase of 129% from the average session volume of 215,884 shares. The stock had previously closed at GBX 1.25 ($0.02).
RTW Biotech Opportunities Stock Up 1.2 %
The stock has a market cap of £423.25 million, a PE ratio of 3.00 and a beta of 0.60. The firm has a fifty day moving average of GBX 1.34 and a 200 day moving average of GBX 1.45.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Further Reading
- Five stocks we like better than RTW Biotech Opportunities
- Earnings Per Share Calculator: How to Calculate EPS
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Using the MarketBeat Dividend Yield Calculator
- Alphabet’s Officially In A Bear Market—Time To Buy?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
